ASP Isotopes (ASPI) Accumulated Expenses (2021 - 2026)

ASP Isotopes' Accumulated Expenses history runs 6 years deep, the most recent figure standing at $4.3 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 98.23% year-over-year to $4.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 98.23% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 87.18% from the prior year.
• Accumulated Expenses improved to $4.3 million in Q1 2026 per ASPI's latest filing, from $3.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $4.3 million in Q1 2026 and bottomed at $361246.0 in Q4 2022.
• The 5-year median for Accumulated Expenses is $1.6 million (2024), against an average of $1.7 million.
• Across the five-year window, Accumulated Expenses surged 749.99% in 2022 and slumped 53.69% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $361246.0 in 2022, then soared by 134.01% to $845344.0 in 2023, then surged by 87.38% to $1.6 million in 2024, then soared by 87.18% to $3.0 million in 2025, then soared by 46.37% to $4.3 million in 2026.
• Per Business Quant, the three latest ASPI Accumulated Expenses figures stand at $4.3 million (Q1 2026), $3.0 million (Q4 2025), and $2.8 million (Q3 2025).